For press inquiries click here to contact us.
Business Insider
Startups are pioneering a dramatic shift in how we spot and treat depression — and you can try some of their new tools right now
Drug Delivery
Sage Therapeutics’ chief scientist on discovering drugs and taking risks
CNBC
With food allergies on the rise, biotech Aimmune is focusing on raising patients’ tolerance
FierceBiotech
Arcus, Infinity team up on triple-combination studies in TNBC and ovarian cancer
FierceBiotech
Despite FDA hold, Epizyme’s tazemetostat posts positive interim data
FierceBiotech
GlaxoSmithKline’s head of dermatology joins JAK developer Aclaris
FierceBiotech
Mental health app maker Mindstrong raises $15M in series B
Xconomy
Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune
Endpoints
Novartis hands Regenxbio $100M in fast cash for vector tech
Please see important disclaimers in the Terms section.
